Nilotinib-13C,d3, CAS 1261398-62-2

Product Description: Nilotinib-13C,d3 is a deuterated labeled Nilotinib[1]. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.

Formula: C27 13CH19D3F3N7O

References: [1]Meirson T, et al. Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors. Oncotarget. 2018 Apr 24;9(31):22158-22183./[2]Weisberg E, et al. Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 2007 Mar 1;109(5):2112-20./[3]Dervis Hakim G, et al. Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model. World J Gastroenterol. 2015 Nov 28;21(44):12576-85./[4]Fujita KI, et al. Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites. J Pharm Sci. 2017 Sep;106(9):2632-2641./[5]Sako H, et al. Antitumor effect of the tyrosine kinase inhibitor Nilotinib on gastrointestinal stromal tumor (GIST) and Imatinib-resistant GIST cells. PLoS One. 2014 Sep 15;9(9):e107613./[6]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

CAS Number: 1261398-62-2

Molecular Weight: 533.53

Research Area: Cancer

Target: Autophagy;Bcr-Abl;Isotope-Labeled Compounds

• Artikelnummer: MEXHY-10159S1-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-10159S1-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK